Analysis of the drug crystals discovered by police 23 Sep 2008 to 20 Mar 2009 in Arak

Journal of Engineering and Applied Sciences

Volumn 6, Issue 11, 2011, Pages 48-51

  Kazemifar, Amir Mohammad ^a   Solhi, Hasan ^b   Badakhshan, Daryiush ^b   Eidi, Mohammad ^b  

^a QAZVIN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b ARAK UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Analysis; Drug crystals; HPLC; Methamphetamine; SHISHEH

Indexed keywords

EID: 84859066417     PISSN: 1816949X     EISSN: 18187803     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. McGregor C, Srisurapanont M, Jittiwutikarn J, Laobhripatr S, Wongtan T and White J. 2005. The nature, time course and severity of methamphetamine withdrawal. Addiction. 100(9): 1320-1329.
2. Nagai N. 1893. Kanyaku maou seibun kenkyuu seiseki (zoku). Yakugaku Zashi. 13: 901.
3. Doyle D. 2005. Hitler's Medical Care. (PDF). Journal of the Royal College of Physicians of Edinburgh. 35: 75-82.
4. Digital Creators Studio Yama-Arashi (2006-04-16). (Various Antidepressants). (In Japanese). - arashi.com/ medical/ antidepressants. htm. Retrieved on 2006-07-14.
5. Tamura M. 1989. Japan: stimulant epidemics past and present. Bulletin on Narcotics. United Nations Office on Drugs and Crime. pp. 83-93.
6. Cunningham J.K. and Liu L.M. 2003. Impacts of Federal ephedrine and pseudo ephedrine regulations on methamphetamine-related hospital admissions. Addiction. 98: 1229-1237.
7. Rothman. 2001. Amphetamine-Type Central Nervous System Potently than they Release Dopamine and Serotonin. Synapse. 39: 32-41.
8. Itzhak Y, Martin J, Ali S. 2002. Methamphetamine-induced dopaminergic neurotoxicity in mice: long-lasting sensitization to the locomotor stimulation and desensitization to the rewarding effects of methamphetamine. Prog Neuropsychopharmacol Biol Psychiatry. 26(6): 1177-1183.
9. C. Davidson, A. J. Gow, T. H. Lee and E. H. Ellinwood. 2001. Methamphetamine neurotoxicity: necrotic and apoptotic mechanisms and relevance to human abuse and treatment. Brain Research Reviews. 36: 1.
10. Yamamoto B. and Zhu W. 1998. The Effects of Methamphetamine on the Production of Free Radicals and Oxidative Stress. The Journal of Pharmacology and Experimental Therapeutics. 287(1).
11. Bennett B., Hollingsworth C., Martin R. and Harp J. 1998. Methamphetamine- induced alterations in dopamine transporter function. Brain Res. 782(1-2): 219-227.
12. Wagner G. C., Carelli R. M., Jarvis M. F. 1985. Pretreatment with ascorbic acid attenuates the neurotoxic effects of methamphetamine in rats. Research Communications in Chemical Pathology and Pharmacology. 47(2): 221-228.
13. Wagner G. C., Carelli R. M., Jarvis M. F. 1986. Ascorbic acid reduces the dopamine depletion induced by methamphetamine and the 1-methyl-4-phenyl pyridinium ion. Neuropharmacology. 25(5): 559-561.
14. Oyler J. M., Cone E. J., Joseph R. E. Jr., Moolchan E. T., Huestis M. A. 2002. Duration of detectable methamphetamine and amphetamine excretion in urine after controlled oral administration of methamphetamine to humans. Clinical Chemistry. 48(10): 1703-1714.
15. Pavlova V., Petrovska-Jovanovic S. 2007. Simultaneous Determination of Amphetamine, Methamphetamine and Determination of Amphetamin, Methamphetami Caffeine in Seized Tablets Byhighperformance Liquid Chromatography Acta Chromatographica. No. 18.
16. Pavlova V., Petrovska-Jovanovic S. 2007. Analytical Study of Amphetamine Andmethamphetamine by Reversephasehigh- Performanceliquidchromatograph Method chemistry. 16(3).
17. U. S. Drug Enforcement Administrtion. 2007. The Executive Policy and Strategic Planning Staff (ADS), supported by the Statistical Services Section.
18. Kan'ya K. 2000. Analysis of Impurities in Methamphetamine and Impurity Profiling. Reports of National Research Institute of Police Science. 53(1): 1-9.